Brokerages predict that Colgate-Palmolive Company (NYSE:CL) will announce $0.73 earnings per share for the current quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Colgate-Palmolive’s earnings. The highest EPS estimate is $0.74 and the lowest is $0.71. Colgate-Palmolive also reported earnings of $0.73 per share in the same quarter last year. The firm is scheduled to report its next earnings results before the market opens on Friday, October 27th.

According to Zacks, analysts expect that Colgate-Palmolive will report full-year earnings of $2.89 per share for the current fiscal year, with EPS estimates ranging from $2.86 to $2.95. For the next fiscal year, analysts anticipate that the firm will post earnings of $3.11 per share, with EPS estimates ranging from $3.04 to $3.16. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that that provide coverage for Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting analysts’ consensus estimates of $0.72. The business had revenue of $3.83 billion during the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. Colgate-Palmolive’s revenue was down .5% on a year-over-year basis. During the same period in the prior year, the company posted $0.70 earnings per share.

Several brokerages have weighed in on CL. Zacks Investment Research cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a report on Thursday, May 25th. BidaskClub cut Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 12th. Jefferies Group LLC reissued a “hold” rating and set a $79.00 price target on shares of Colgate-Palmolive in a report on Thursday, August 24th. Finally, Deutsche Bank AG reissued a “hold” rating and set a $75.00 price target on shares of Colgate-Palmolive in a report on Monday, July 24th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $75.82.

Shares of Colgate-Palmolive (NYSE CL) traded up 0.73% during mid-day trading on Thursday, reaching $72.18. The company’s stock had a trading volume of 1,492,714 shares. Colgate-Palmolive has a 52-week low of $63.43 and a 52-week high of $77.27. The firm has a market cap of $63.57 billion, a price-to-earnings ratio of 26.82 and a beta of 0.80. The firm has a 50 day moving average price of $71.63 and a 200 day moving average price of $73.31.

ILLEGAL ACTIVITY WARNING: “Analysts Anticipate Colgate-Palmolive Company (CL) to Post $0.73 EPS” was published by American Banking News and is the property of of American Banking News. If you are reading this news story on another website, it was stolen and republished in violation of U.S. and international trademark and copyright legislation. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/09/14/analysts-anticipate-colgate-palmolive-company-cl-to-post-0-73-eps.html.

In related news, Vice Chairman Franck J. Moison sold 35,000 shares of the business’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $71.52, for a total transaction of $2,503,200.00. Following the sale, the insider now owns 201,411 shares in the company, valued at approximately $14,404,914.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Patricia Verduin sold 3,833 shares of the business’s stock in a transaction on Monday, July 17th. The stock was sold at an average price of $72.41, for a total value of $277,547.53. Following the sale, the insider now owns 53,022 shares in the company, valued at approximately $3,839,323.02. The disclosure for this sale can be found here. Insiders have sold a total of 217,969 shares of company stock worth $15,693,933 in the last 90 days. 1.02% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently modified their holdings of CL. American Beacon Advisors Inc. bought a new stake in shares of Colgate-Palmolive in the 1st quarter valued at about $102,000. Proficio Capital Partners LLC grew its position in shares of Colgate-Palmolive by 16.9% in the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after buying an additional 207 shares during the last quarter. OLD Second National Bank of Aurora bought a new stake in shares of Colgate-Palmolive in the 2nd quarter valued at about $109,000. Krilogy Financial LLC grew its position in shares of Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after buying an additional 289 shares during the last quarter. Finally, Harbour Capital Advisors LLC bought a new stake in shares of Colgate-Palmolive in the 1st quarter valued at about $121,000. Institutional investors and hedge funds own 73.16% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.